Acute Dyskinesia on Starting Methylphenidate After Risperidone Withdrawal

Pediatric Neurology

Volumn 37, Issue 4, 2007, Pages 287-288

  Hollis, Chris P ^a   Thompson, Anne ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LINCOLNSHIRE PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMOXETINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; METHYLPHENIDATE; NEUROLEPTIC AGENT; PSYCHOSTIMULANT AGENT; RISPERIDONE;

ACUTE DISEASE; ARTICLE; ATTENTION DEFICIT DISORDER; CASE REPORT; CHILD; COMORBIDITY; CONDUCT DISORDER; DRUG DOSE TITRATION; DRUG EXPOSURE; DRUG WITHDRAWAL; DYSKINESIA; HUMAN; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ACUTE DISEASE; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DELAYED-ACTION PREPARATIONS; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; DYSKINESIA, DRUG-INDUCED; HUMANS; MALE; METHYLPHENIDATE; RECEPTORS, DOPAMINE; RETREATMENT; RISPERIDONE;

EID: 34548844470     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.05.017     Document Type: Article

References (7)

1. Lipkin P.H., Goldstein I.J., and Adesman A.R. Tics and dyskinesias associated with stimulant treatment in attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 148 (1994) 859-861
2. Senecky Y., Lobel D., Diamond G.W., Weitz R., and Inbar D. Isolated facial dyskinesia: A methylphenidate-induced movement disorder. Pediatr Neurol 27 (2002) 224-226
3. Conner D.F., Benjamin S., and Ozbayrak K.R. Case study: Neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment. J Am Acad Child Adolesc Psychiatry 34 (1995) 1490-1494
4. Conner D.F. Stimulants and neuroleptic withdrawal dyskinesia. J Am Acad Child Adolesc Psychiatry 37 (1998) 247-248
5. Benjamin E., and Salek S. Stimulant-atypical antipsychotic interaction and acute dystonia. J Am Acad Child Adol Psychiatry 44 (2005) 510-511
6. Husain A., Chapel J., and Malek-Ahmadi P. Methylphenidate, neuroleptics and dyskinesia-dystonia. Can J Psychiatry 25 (1980) 254-258
7. Kutcher S., Aman M., Brooks S.J., et al. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): Clinical implications and treatment practice suggestions. Eur Neuropsychopharmacol 14 (2003) 11-28